2025-07-08 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data. The report is structured to provide a concise overview in English, followed by a simple analysis of the key metrics.

**Colgate-Palmolive (CL) Analysis**

Colgate-Palmolive Co. is a global consumer products company specializing in the production, distribution and provision of household, health care, personal care and veterinary products.

**1. Performance vs. S&P 500 (VOO)**

*   **CL Cumulative Return:** 21.25%
*   **VOO Cumulative Return:** 95.42%
*   **Spread (CL - VOO):** -74.6
*   **Spread Range:** Max: 7.9, Min: -74.6
*   **Relative Spread:** 0.0

**Analysis:** CL has significantly underperformed the S&P 500 over the period.  The relative spread indicates the current underperformance is at the lowest end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha    | Beta    | Cap(B) |
|------------|---------|---------|----------|---------|--------|
| 2015-2017  | 13.0%   | 4.5%    | -16.0%   | 0.0     | 61.5   |
| 2016-2018  | -11.0%  | 65.2%   | -29.0%   | 0.1     | 48.5   |
| 2017-2019  | 7.0%    | 65.2%   | -22.0%   | 0.1     | 56.1   |
| 2018-2020  | 18.0%   | 65.2%   | -2.0%    | 0.6     | 69.7   |
| 2019-2021  | 30.0%   | 58.6%   | -19.0%   | 0.7     | 69.6   |
| 2020-2022  | 7.0%    | 69.0%   | 5.0%     | 0.7     | 64.2   |
| 2021-2023  | 6.0%    | 69.0%   | -12.0%   | 0.8     | 65.0   |
| 2022-2024  | 13.0%   | 69.0%   | -12.0%   | 0.8     | 74.1   |
| 2023-2025  | 8.0%   | 70.6%   | -39.0%   | 0.3     | 75.7   |

**Analysis:** The table shows Colgate-Palmolive's performance metrics over rolling three-year periods.
*   **CAGR (Compound Annual Growth Rate):** Varies across periods, showing fluctuations in growth.
*   **MDD (Maximum Drawdown):** High MDD values in several periods indicate significant potential for loss from peak to trough.
*   **Alpha:** Predominantly negative alpha suggests underperformance relative to a benchmark (market index).
*   **Beta:** Low Beta values indicate less volatility than the market.
*   **Cap(B):** Shows the market capitalization in billions of dollars, generally trending upward.

**2. Recent Stock Price Movement**

*   **Current Price:** 92.78
*   **Last Market Data:** Price: 93.35, Previous Close: 92.78, Change: 0.61
*   **5-day Moving Average:** 91.37
*   **20-day Moving Average:** 90.1355
*   **60-day Moving Average:** 91.2168

**Analysis:** The stock price is above its 5-day, 20-day, and 60-day moving averages, suggesting a short-term upward trend. The slight increase in the last market data reflects a small positive change.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3302 (Low Risk)
*   **RSI:** 48.51
*   **PPO:** 0.5229
*   **Hybrid Signal:** cash_1%_Buy 80% of cash (37 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Spread Change:** 0.0 (Short-term decrease)
*   **Expected Return:** -3585.3%

**Analysis:**

*   The MRI indicates a low-risk environment for the stock.
*   The RSI is near the neutral level, suggesting neither overbought nor oversold conditions.
*   PPO being positive suggests a slightly bullish trend.
*   The Hybrid Signal suggests a cautious buying strategy with a high cash allocation.
*   A significant, negative Expected Return warrants caution as it predicts substantial underperformance compared to the S&P 500 in the long term.
*   The increase of the `change: 0.61` from `previousClose: 92.78` reflects a sudden price movement that could be related to breaking news or market events.

**4. Recent News & Significant Events**

*   **2025-07-06:** Major business developments, regulatory changes, or market events.
*   **2025-07-05:** Analyst discussions on recent performance, industry trends, and global economic factors.
*   **2025-07-07:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-04:** Market experts highlight risks and opportunities, advising monitoring of recent news and company announcements.

**Analysis:** Recent news suggests volatility and potential market-moving events impacting CL. Investors should remain vigilant and monitor news related to the company.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-04-25 | 0.85 | 4.91 B$   |
| 2024-10-25 | 0.9  | 5.03 B$   |
| 2024-07-26 | 0.89 | 5.06 B$   |
| 2024-04-26 | 0.83 | 5.07 B$   |
| 2025-04-25 | 0.83 | 5.07 B$   |

**Analysis:** The quarterly earnings data shows a relatively stable revenue around the 5B$ mark, though there has been a slight decline in the most recent quarter. EPS has fluctuated, but no significant growth is evident.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $4.91B    | 60.82%        |
| 2024-12-31 | $4.95B    | 60.30%        |
| 2024-09-30 | $5.03B    | 61.08%        |
| 2024-06-30 | $5.06B    | 60.62%        |
| 2024-03-31 | $5.07B    | 60.00%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $0.36B    | 190.08%   |
| 2024-12-31 | $0.21B    | 348.58%   |
| 2024-09-30 | $0.43B    | 169.43%   |
| 2024-06-30 | $0.12B    | 594.31%   |
| 2024-03-31 | $0.23B    | 296.96%   |

**Analysis:**
*   **Revenue and Profitability:** The revenue is relatively stable but shows a recent slight decline. The profit margins are consistently high, indicating strong operational efficiency.
*   **Capital and Profitability:** The equity fluctuates significantly, which affects the ROE. The ROE values are exceptionally high, suggesting effective use of equity to generate profits. However, the fluctuating equity base makes it difficult to ascertain a consistent trend.

**7. 종합적인 분석 (Overall Analysis)**

Colgate-Palmolive (CL) has underperformed the S&P 500 significantly. While its MRI suggests a low-risk investment, the negative expected return raises concerns about future relative performance.  Recent news indicates potential volatility. Revenue and earnings have been stable, but there is no significant growth. The hybrid signal gives a caution-based recommendation, and the ROE values are exceptionally high. Therefore, a cautious approach is warranted. Investors should carefully monitor any news and industry trends affecting the company.

